Arena Pharmaceuticals, Inc. news

   Watch this stock
Showing stories 11 - 20 of about 95   

Articles published

ARNA 2.13 +0.01 (0.47%)
price chart
Arena Pharmaceuticals Inc (NASDAQ:ARNA) Quarterly Sentiment Report
Arena Pharmaceuticals Inc (NASDAQ:ARNA) hedge funds sentiment decreased to 0.98 in Q2 2015. Its down -0.26, from 1.24 in 2015Q1.
Analyst Price Target Update on Arena Pharmaceuticals, Inc.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA): The mean estimate for the short term price target for Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stands at $5.17 according to 3 Analysts. The higher price target estimate for the stock has been calculated at $8 ...
Arena Pharmaceuticals (ARNA) - Research Analysts' Weekly Ratings Changes
11/11/2015 - Arena Pharmaceuticals had its “hold” rating reaffirmed by analysts at Needham & Company LLC. 11/11/2015 - Arena Pharmaceuticals had its price target lowered by analysts at RBC Capital from $5.00 to $2.00. They now have a “sector ...
Arena Pharmaceuticals Receives $4.90 Consensus Target Price from Brokerages ...  STORM
Small cap stock picking: Repros Therapeutics Inc (NASDAQ:RPRX), Arena ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) closed at $2.12 with an increase of 1.92%. The $514.21M company on November 10, 2015 reported financial results for the third quarter ended September 30, 2015, and provided a corporate update.
How it All Plays Out - Research on Arena Pharmaceuticals, XOMA, Ekso Bionics ...
On April 20, 2011, Arena Pharmaceuticals, Inc. was trading at USD 1.21, and has since experienced gains of 62%. Among multiple factors, the Company's persistent R&D efforts to bring innovative medicines targeting G protein-coupled receptors to patients ...
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Stock Update
Sell-side brokerage firm are predicting that Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) will post earnings per share of $-0.1 for the current fiscal quarter.
Ratings and Sentiment Update on Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) has been given a 2.5 average broker rating according to Zacks Research. Zacks compiles research brokerage recommendations and places them into a simplified Buy/Sell scale.
Arena Pharmaceuticals, Inc. Price Target Update
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) stock has received a short term price target of $ 5.17 from 3 Analyst. The share price can be expected to fluctuate from the mean short term target, can be seen from the standard deviation reading of $2.02.
What's in Arena Pharmaceuticals, Inc. After Forming Double Bottom Chart Pattern?
The chart of Arena Pharmaceuticals, Inc. (ARNA) shows a double bottom with $1.51 target or 13.00% below today's $1.74 share price.
Arena Pharmaceuticals Short Interest Down 11.0% in October (ARNA)  Dakota Financial News
Current Trade Stocks Highlights: JetBlue Airways Corporation (NASDAQ:JBLU ...  wsnewspublishers
Scorching Hot Biotech Stocks Tape: Arena Pharmaceuticals, Inc. (ARNA ...
Please connect to Arena's website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary.